Bioinformatics analysis revealed that GBM exhibited elevated ADORA1 expression, which was positively correlated with malignancy-associated clinical features such as IDH wild-type and 1p/19q non-co-deletion, as indicated by public databases (16). This evidence concerns the gene IDH1 and glioblastoma.